185 related articles for article (PubMed ID: 26325528)
21. [Professor Drago Vrbanić - the important contribution to the development of oncology in Rijeka].
Pavlovic P
Acta Med Hist Adriat; 2013; 11(1):165-8. PubMed ID: 23883093
[TBL] [Abstract][Full Text] [Related]
22. SGO future forward: Our greatest challenges are our greatest opportunities.
Mutch DG
Gynecol Oncol; 2010 Sep; 118(3):212-5. PubMed ID: 20576286
[No Abstract] [Full Text] [Related]
23. One score + 11 = 2000.
Creasman WT
Gynecol Oncol; 1989 Sep; 34(3):255-7. PubMed ID: 2767516
[No Abstract] [Full Text] [Related]
24. My friend and colleague, Marie Plante, drew my attention to the fact that currently, the positions of president of the most distinguished societies of gynecologic oncology are held by women. Introduction.
Beller U
Int J Gynecol Cancer; 2014 Jan; 24(1):1. PubMed ID: 24356409
[No Abstract] [Full Text] [Related]
25. The 4th European Society for Medical Oncology Asia Congress: bridging ultimate cancer care with real-world practice for the Asian practitioner in gynecological cancers.
Ngoi NY; Tan DS
J Gynecol Oncol; 2019 Mar; 30(2):e48. PubMed ID: 30740965
[No Abstract] [Full Text] [Related]
26. Opioid Use in Gynecologic Oncology; Balancing Efficacy, Accessibility and Safety: An SGO Clinical Practice Statement.
Lefkowits C; Duska L
Gynecol Oncol; 2017 Feb; 144(2):232-234. PubMed ID: 27988048
[No Abstract] [Full Text] [Related]
27. The Society of Gynecologic Oncologists--a tradition of excellence.
van Nagell JR
Gynecol Oncol; 1994 Oct; 55(1):1-5. PubMed ID: 7959249
[No Abstract] [Full Text] [Related]
28. Joint ENGOT and GOG Foundation requirements for trials with industry partners.
Vergote I; Coleman RL; Pignata S; Bookman MA; Marth C; Herzog TJ; Gonzalez-Martin A; Copeland LJ; ;
Gynecol Oncol; 2019 Aug; 154(2):255-258. PubMed ID: 31331494
[No Abstract] [Full Text] [Related]
29. The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.
Bacon M; Kitchener H; Stuart GC; Vermorken JB;
Int J Gynecol Cancer; 2011 May; 21(4):746-9. PubMed ID: 21543935
[TBL] [Abstract][Full Text] [Related]
30. SGO presidential address February 3, 2003.
Austin JM
Gynecol Oncol; 2004 Feb; 92(2):513-8. PubMed ID: 14766240
[No Abstract] [Full Text] [Related]
31. Organization, function, and accomplishments of the Gynecologic Oncology Group.
Park RC; Hoskins WJ; Weiner JM
Cancer Invest; 2002; 20(5-6):787-92. PubMed ID: 12197237
[No Abstract] [Full Text] [Related]
32. The Janeway Lecture. Gynecologic oncology in the last quarter century.
Averette HE; Estape R; Angioli R
Cancer J Sci Am; 1998; 4(6):339-44. PubMed ID: 9853129
[No Abstract] [Full Text] [Related]
33. Gynaecologic oncology: looking back and moving ahead.
Onnis A
Eur J Gynaecol Oncol; 2001; 22(3):170-3. PubMed ID: 11501767
[No Abstract] [Full Text] [Related]
34. Clinical needs for transgender men in the gynecologic oncology setting.
Stenzel AE; Moysich KB; Ferrando CA; Starbuck KD
Gynecol Oncol; 2020 Dec; 159(3):899-905. PubMed ID: 33004214
[TBL] [Abstract][Full Text] [Related]
35. Second Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO): a turning point from good old days to a better future.
Ryu HS; Suh DH
Gynecol Oncol; 2012 Jun; 125(3):518-9. PubMed ID: 22366152
[No Abstract] [Full Text] [Related]
36. The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017.
Tominaga E; Kobayashi Y; Aoki D
J Gynecol Oncol; 2018 Mar; 29(2):e33. PubMed ID: 29468857
[No Abstract] [Full Text] [Related]
37. The American College of Surgeons Oncology Group: its genesis and future directions.
Wells SA
Bull Am Coll Surg; 1998 Jun; 83(6):13-9. PubMed ID: 10180258
[No Abstract] [Full Text] [Related]
38. FIGO Cancer Report 2012.
Denny L; Quinn M; Hacker N
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S89. PubMed ID: 22999508
[No Abstract] [Full Text] [Related]
39. Gynecologic oncology.
Curr Opin Obstet Gynecol; 1992 Feb; 4(1):151-75. PubMed ID: 1543825
[No Abstract] [Full Text] [Related]
40. Testimony before the Subcommittee on Criminal Justice, Drug Policy and Human Resources: Committee on Government Reform United States House of Representatives.
Karlan BY
Gynecol Oncol; 2005 Nov; 99(2):257-60. PubMed ID: 16315346
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
